Hal W Hirte

5PUBLICATIONS
9CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 27, 2025
Incidence of Venous Thromboembolism in Newly Diagnosed Glioblastoma and Associated Risk Factors: A Retrospective Chart Review.

Duaa Binjabal, Nasser Al Majarafi, Gregory R Pond

|Jan 30, 2020
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86).

Neesha C Dhani, Hal W Hirte, Lisa Wang

|Dec 14, 2019
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.

Amit M Oza, Ursula A Matulonis, Angeles Alvarez Secord

Pageof 1